Staging, Restaging, and Treatment Response Assessment in Lymphomas: What We Should Know
J Nucl Med
.
2018 Apr;59(4):714-715.
doi: 10.2967/jnumed.117.205351.
Epub 2017 Dec 21.
Authors
Salim Kanoun
1
,
Anne-Segolène Cottereau
,
Alina Berriolo-Riedinger
,
Michel Meignan
,
Olivier Casasnovas
,
Fréderic Courbon
,
Françoise Kraeber-Bodéré
Affiliation
1
The University Cancer Institute Toulouse Oncopole 1 Avenue Joliot Curie 31100 Toulouse, France E-mail: Salim.kanoun@gmail.com.
PMID:
29269571
DOI:
10.2967/jnumed.117.205351
No abstract available
Publication types
Letter
Comment
MeSH terms
Fluorodeoxyglucose F18*
Humans
Lymphoma*
Positron Emission Tomography Computed Tomography
Positron-Emission Tomography
Substances
Fluorodeoxyglucose F18